首页|新型1,2-二取代肼的设计合成及抗癌活性初步研究

新型1,2-二取代肼的设计合成及抗癌活性初步研究

扫码查看
设计合成了 13个新型1,2-二取代肼,其中包括10个2-芳基-1-(4-(N-异丙基)氨甲酰基)苄肼(9a~9j)、2个2-芳甲基-1-(4-(N-异丙基)氨甲酰基)苄肼(13a~13b)以及2-对甲基苯甲酰基-1-(4-(N-异丙基)氨甲酰基)苄肼(14)。噻唑蓝法(MTT)检测发现,目标化合物对大鼠脑胶质瘤细胞(C6)、小鼠黑色素瘤复苏细胞(K1735)、人肝癌细胞(HepG-2)、人结肠癌细胞(SW620)、人乳腺癌细胞(MDA-MB-231)和人恶性黑色素瘤(A357)共六株肿瘤细胞大致显示出比阳性对照药丙卡巴肼(Pcb)更好的抗肿瘤活性。Pcb对小鼠黑色素瘤细胞(B16)敏感,在孵育48 h条件下,2-(4-甲氧基)苯基-1-(4-(N-异丙基)氨甲酰基)苄肼(9a)、2-(6-甲氧基-2-基)萘基-1-(4-(N-异丙基)氨甲酰基)苄肼(9b)和2-(3-溴)苯基-1-(4-(N-异丙基)氨甲酰基)苄肼(9i)均表现出比Pcb更强的抗癌活性;9a对除C6和SW620外的其它五株肿瘤细胞展现出最强的抗癌活性,其中,对 MDA-MB-231 细胞的 IC50值为(10。8±0。9)μmol/L;13b 对 C6 的抑制活性最强,IC50值为(15。9±3。1)μmol/L;9e 则对SW620的抑制活性最高,IC50值为(62。7±1。4)μmol/L。对于化合物9a~9j,当芳基Ar上的取代基为吸电子效应基团时,通常处于间位比处于对位的抗癌活性要高(9g>9f,9i>9h);而当取代基为供电子效应的基团时,就没有这样的规律性;对于SW620而言,芳环上有弱的供电子诱导效应取代基对提高增殖抑制活性有利。化合物9a、9b、13a和13b对小鼠胚胎成纤维细胞(3T3)的增殖抑制活性较高,尤其是化合物9a和13a,在孵育48 h条件下IC50值分别为(24。9±1。2)和(13。9±1。7)μmol/L。
Design,Synthesis,and Preliminary Anti-tumor Activity Studies of Novel 1,2-Disubstituted Hydrazines
Thirteen 1,2-disubstituted hydrazines,including ten 2-aryl-1-(4-(N-isopropyl)aminoformyl)benzyl hydrazines(9a~9j),two 2-aryl methylene-1-(4-(N-isopropyl)aminoformyl)benzyl hydrazines(13a~13b),and 2-(4-methyl)benzoyl-1-(4-(N-isopropyl)aminoformyl)benzyl hydrazine(14)have been designed and synthesized.By employing methyl thiazolyl tetrazolium(MTT)assay,generally all the title compounds were shown with better anti-cancer activity against rat glioma cells(C6),mouse melanoma cells(K1735),human liver cancer cells(HepG-2),human colon cancer cells(SW620),human breast cancer cells(MDA-MB-231),and human malignant melanoma cells(A357)than the positive procarbazine(Pcb).It was demonstrated that Pcb is sensitive to murine melanoma cells(B16).However,under the condition of 48-hour incubation,9a,9b,and 9i were confirmed more active against B16 cells than Pcb.More interestingly,9a was the most active anti-cancer agent against the five cancer cell lines except both C6 and SW620 cell lines among the 13 title compounds,its IC50 value against MDA-MB-231 cells was(10.8±0.9)μmol/L,whilst 13b was the most active against C6 cells with IC50 value of(15.9±3.1)μmol/L,and 9e was the most active against SW620 cells with IC50 value of(62.7±1.4)μmol/L.It was found that when the substituent in aryl group of 9a~9j was electron-withdrawal,the anti-cancer activity of compound with substituent at me-ta-position was better that at para-position(9g>9f,9i>9h).Intriguingly,when the substituent was an electron-donor group,this law was lost.It was also identified that the anti-cancer activity against SW620 cells will be enhanced with the existence of a weak electron-donor inductive group.Mouse embryonic fibroblasts(3T3)were applied here.Compounds 9a,9b,13a,and 13b were displayed sensitive to this cell line.IC50 values of 9a,and 13a were(24.9±1.2),and(13.9±1.7)μmol/L,respec-tively.

1,2-disubstituted hydrazinesanti-canceralkylation agentprodrugdrug design-synthesis

胡健灵、张超、朱文达、何业谱、彭姝羚、陈振强、李明月、刘志军、陈河如

展开 >

暨南大学药学院中药及天然药物研究所 中药现代化与创新药物研究国际合作联合实验室 广州 510632

广州药本君安医药科技股份有限公司 广州 510663

暨南大学 广东省中药药效物质基础及创新药物研究重点实验室 广州 510632

暨南大学 生物活性分子与成药性优化全国重点实验室 广州 510632

展开 >

1,2-二取代肼 抗肿瘤 烷化剂 前药 药物设计合成

广东省自然科学基金

2021A1515011238

2024

有机化学
中国化学会,中国科学院上海有机化学研究所

有机化学

CSTPCD北大核心
影响因子:1.09
ISSN:0253-2786
年,卷(期):2024.44(6)